QBR106646(74080)

• Research type

  Research Study

• Full title

  Randomised, Double-Blind, Single, 6 mg Fixed Dose, Two-Treatment, Two Period, Two-Sequence, Two-Way Crossover Comparative Pharmacokinetic and Pharmacodynamic (Phase I) Study of RGB-02 compared to Neulasta in Healthy Adult Subjects

• IRAS ID

  83237

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  Gedeon Richter Plc

• Eudract number

  2011-001737-17

• Research summary

  Research Summary not published at request of researcher

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  11/IE/0126

• Date of REC Opinion

  31 Aug 2011

• REC opinion

  Further Information Favourable Opinion